Tissue plasminogen activator (tPA) treatment for COVID_19 associated acute respiratory distress syndrome (ARDS): A case report

Authors

  • Muhammad Mazharul Hoque Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh
  • Motiul Islam Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh
  • Tarikul Hamid Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh
  • Rabiul Halim Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh
  • Rajib Hasan Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh
  • Kazi Nuruddin Ahmed Department of Critical Care, Asgar Ali Hospital, Dhaka-1204, Bangladesh

DOI:

https://doi.org/10.3329/bccj.v9i1.53059

Keywords:

Tissue plasminogen, tPA, ARDS, COVID‐19

Abstract

Coagulopathy has proven to be a common complication of the novel coronavirus SARS-CoV-21. Some of the COVID-19 associated pneumonia patients exhibit relatively preserved lung compliance and high alveolar‐arterial oxygen gradient. Pathology reports consistently demonstrate diffuse pulmonary microthrombi on autopsy, consistent with a vascular occlusive etiology of respiratory failure rather than the more classic findings of ARDS2. Pulmonary microthrombi induced respiratory failure is very difficult to prove because the patients are so critically ill that transfer to CT suit to do CTPA often becomes unsafe for the patients. Moreover, performing V/Q scan is increasingly difficult in such settings. Here we report a case of severe COVID-19 associated respiratory failure who was treated with tissue plasminogen activator (tPA) on clinical ground.

Bangladesh Crit Care J March 2021; 9(1): 49-51

Downloads

Download data is not yet available.
Abstract
27
PDF
43

Downloads

Published

2021-04-18

How to Cite

Hoque, M. M., Islam, M., Hamid, T., Halim, R., Hasan, R., & Ahmed, K. N. (2021). Tissue plasminogen activator (tPA) treatment for COVID_19 associated acute respiratory distress syndrome (ARDS): A case report. Bangladesh Critical Care Journal, 9(1), 49–51. https://doi.org/10.3329/bccj.v9i1.53059

Issue

Vol. 9 No. 1 (2021)

Section

Case Reports

License

Upon acceptance for publication the copyright of the paper automatically transfers to the BCCJ and will not be published elsewhere either in part or whole without written permission of the copyright holder.

Except for personal use, no part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, photocopying, recording or otherwise without the prior written permission of the publisher.